NCT04682184View on ClinicalTrials.gov

A Study of Continuous Heart Rate Monitoring in Healthy Participants

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

January 27, 2021

Primary Completion Date

March 25, 2021

Study Completion Date

March 25, 2021

Conditions
Healthy
Interventions
DRUG

Propranolol

Administered orally.

DRUG

Pseudoephedrine

Administered orally.

DEVICE

Wearable Biosensor Patch Device

Biosensor patch device attached to the chest and worn throughout the trial with replacement of biosensor every 7 days.

Trial Locations (1)

138623

Lilly Centre for Clinical Pharmacology, Singapore

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT04682184 - A Study of Continuous Heart Rate Monitoring in Healthy Participants | Biotech Hunter | Biotech Hunter